Dipyridamole Completed Phase 4 Trials for Endotoxaemia Prevention

IndicationsStatusPurposePhase
CompletedPrevention4
clinicaltrials.gov IdentifierTitleDrugs
NCT01091571The Effects of Oral Dipyridamole Treatment on the Innate Immune Response During Human Endotoxemia